🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Artificial Intelligence for Highly Myopic Cataract

Recruitingn/aAges any - anyAllShanghai High Myopia Study Group
NCT06616506 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study aims to establish a multi-center artificial intelligence model for the accurate calculation of intraocular lens and its clinical application in highly myopic cataract, so as to improve the accuracy of the prediction of postoperative diopter in highly myopic cataract patients.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: Axial length ≥ 26 mm and patients with high myopia complicated by cataracts who visit our hospital. Preoperative anterior segment photography and cataract severity assessment, along with fundus OCT examination, have been performed. If surgical treatment is conducted, the postoperative follow-up period should be no less than 1 month. There are no missing clinical data before and after the surgery. Exclusion Criteria: Patients who are unable to cooperate with the required examinations for this study.
💊

What it tests

  • newly-invented AI model
📍

Where

1 site
Eye and ENT Hospital of Fudan University
Shanghai, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy